ES2649370T3 - Método de detección diagnóstica basado en la proteómica para sinusitis crónica - Google Patents

Método de detección diagnóstica basado en la proteómica para sinusitis crónica Download PDF

Info

Publication number
ES2649370T3
ES2649370T3 ES12726000.8T ES12726000T ES2649370T3 ES 2649370 T3 ES2649370 T3 ES 2649370T3 ES 12726000 T ES12726000 T ES 12726000T ES 2649370 T3 ES2649370 T3 ES 2649370T3
Authority
ES
Spain
Prior art keywords
protein
omp
hint
biomarkers
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12726000.8T
Other languages
English (en)
Spanish (es)
Inventor
Subinoy DAS
Lauren O. Bakaletz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Ohio State University
Nationwide Children's Hospital
Original Assignee
The Ohio State University
Nationwide Children's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Ohio State University, Nationwide Children's Hospital filed Critical The Ohio State University
Application granted granted Critical
Publication of ES2649370T3 publication Critical patent/ES2649370T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/14—Disorders of ear, nose or throat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
ES12726000.8T 2011-06-06 2012-06-05 Método de detección diagnóstica basado en la proteómica para sinusitis crónica Active ES2649370T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161493829P 2011-06-06 2011-06-06
US201161493829P 2011-06-06
PCT/US2012/040910 WO2012170422A1 (en) 2011-06-06 2012-06-05 Proteomics based diagnostic detection method for chronic sinusitis

Publications (1)

Publication Number Publication Date
ES2649370T3 true ES2649370T3 (es) 2018-01-11

Family

ID=46208851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12726000.8T Active ES2649370T3 (es) 2011-06-06 2012-06-05 Método de detección diagnóstica basado en la proteómica para sinusitis crónica

Country Status (9)

Country Link
US (4) US9568472B2 (enExample)
EP (1) EP2718722B1 (enExample)
JP (2) JP6050337B2 (enExample)
AU (1) AU2012268380C1 (enExample)
CA (1) CA2838488C (enExample)
DK (1) DK2718722T3 (enExample)
ES (1) ES2649370T3 (enExample)
PL (1) PL2718722T3 (enExample)
WO (1) WO2012170422A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG194886A1 (en) * 2011-05-11 2013-12-30 Riesbeck Healthcare Sweden Ab Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
AU2012268380C1 (en) * 2011-06-06 2017-03-23 Nationwide Children's Hospital, Inc. Proteomics based diagnostic detection method for chronic sinusitis
EP2810078A4 (en) * 2012-02-01 2016-02-17 Oklahoma Med Res Found HUMAN STREPTOCOCCUS PNEUMONIAE ANTIBODIES AND APPLICATIONS THEREOF
CA2921005A1 (en) * 2013-08-16 2015-02-19 Ohio State Innovation Foundation Compositions and methods for modulating dna methylation
US11650213B2 (en) 2015-03-30 2023-05-16 Entvantage Diagnostics, Inc. Devices and assays for diagnosis of viral and bacterial infections
US10921320B2 (en) 2015-03-30 2021-02-16 Entvantage Diagnostics, Inc. Devices and methods for diagnosis of sinusitis
ES2655974T3 (es) 2015-03-30 2018-02-22 Entvantage Diagnostics, Inc. Dispositivos y análisis para el diagnóstico de la sinusitis
AU2018244352A1 (en) 2017-03-28 2019-10-10 Entvantage Diagnostics, Inc. Devices and methods for diagnosis of sinusitis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0664065B2 (ja) * 1985-12-23 1994-08-22 日水製薬株式会社 菌体外膜保有菌の免疫学的測定法
US5763262A (en) 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
KR910014706A (ko) 1990-01-10 1991-08-31 원본미기재 세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
US20020164354A1 (en) 1998-09-30 2002-11-07 Barenkamp Stephen J. High molecular weight surface proteins of non-typeable haemphilus
US5415994A (en) 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
US20080254997A1 (en) * 2004-03-18 2008-10-16 Nissui Pharmaceutical Co., Ltd. Kit, Device and Method For Analyzing Biological Substance
WO2010079739A1 (ja) * 2009-01-07 2010-07-15 大塚製薬株式会社 全インフルエンザ菌の測定方法
EP2405938A2 (en) * 2009-02-13 2012-01-18 Intercell AG Nontypable haemophilus influenzae antigens
US20120276145A1 (en) * 2011-03-28 2012-11-01 House Research Institute Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
AU2012268380C1 (en) * 2011-06-06 2017-03-23 Nationwide Children's Hospital, Inc. Proteomics based diagnostic detection method for chronic sinusitis

Also Published As

Publication number Publication date
CA2838488A1 (en) 2012-12-13
AU2012268380C1 (en) 2017-03-23
EP2718722A1 (en) 2014-04-16
US20190004046A1 (en) 2019-01-03
US10725040B2 (en) 2020-07-28
WO2012170422A1 (en) 2012-12-13
AU2012268380A1 (en) 2014-01-16
CA2838488C (en) 2020-06-30
US20140314876A1 (en) 2014-10-23
JP2014523525A (ja) 2014-09-11
JP2016194532A (ja) 2016-11-17
US20170184589A1 (en) 2017-06-29
US20190324037A1 (en) 2019-10-24
DK2718722T3 (en) 2018-01-15
PL2718722T3 (pl) 2018-04-30
US10345300B2 (en) 2019-07-09
EP2718722B1 (en) 2017-10-18
JP6050337B2 (ja) 2016-12-21
US9568472B2 (en) 2017-02-14
US10048261B2 (en) 2018-08-14
AU2012268380B2 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
Sabarth et al. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis
Kojima et al. Human gingival crevicular fluid contains MRP8 (S100A8) and MRP14 (S100A9), two calcium-binding proteins of the S100 family
US10725040B2 (en) Proteomics based diagnostic detection method for chronic sinusitis
McAtee et al. Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by “proteome” technologies.
McAtee et al. Characterization of a Helicobacter pylori vaccine candidate by proteome techniques
Phadke et al. Analysis of the outer membrane proteome of Caulobacter crescentus by two‐dimensional electrophoresis and mass spectrometry
Maeda et al. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan
Toledo et al. The lipid raft proteome of Borrelia burgdorferi
Ying et al. Identification of novel key molecules involved in spatial memory impairment in triple transgenic mice of Alzheimer’s disease
Zhang et al. Complex spatial organization and flagellin composition of flagellar propeller from marine magnetotactic ovoid strain MO-1
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
Li et al. Proteomics of a toxic dinoflagellate Alexandrium catenella DH01: Detection and identification of cell surface proteins using fluorescent labeling
Zheng et al. Combining blue native polyacrylamide gel electrophoresis with liquid chromatography tandem mass spectrometry as an effective strategy for analyzing potential membrane protein complexes of Mycobacterium bovis bacillus Calmette-Guerin
DE602004024423D1 (de) Impfstoff mit lawsonia intracellularis-untereinheit
Vandahl et al. Proteome analysis of Chiamydia pneumoniae
Rylev et al. Proteomic and immunoproteomic analysis of Aggregatibacter actinomycetemcomitans JP2 clone strain HK1651
AR030292A1 (es) Una proteina gapc; su metodo de produccion y su uso; un polinucleotido aislado y su uso; un vector recombinante; una celula huesped; una composicion de vacuna y su metodo de produccion; anticuerpos y sus usos; y un kit de inmunodiagnostico
Jung et al. Two-dimensional gel electrophoresis of Helicobacter pylori for proteomic analysis
Komatsu Edman sequencing of proteins from 2D gels
Zhu et al. Sampling human indigenous saliva peptidome using a lollipop-like ultrafiltration probe: simplify and enhance peptide detection for clinical mass spectrometry
Mutavhatsindi et al. Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis
Ang et al. ANALYSIS OF PROTEOME OF MYCOBACTERIUM TUBERCULOSIS H37Rv AND A MALAYSIA CLINICAL ISOLATE (TB138) BY 2-D GEL ANALYSIS
Ries Determining the Location of Tektins within a Vital Molecular Machine
Kim et al. Analysis of Vibrio parahaemolyticus OMPs and production of antibodies against OMPs
LIU et al. Expression and clinical application of recombinant fusion protein CFP10-MPT48-TB8. 4 of Mycobacterium tuberculosts